PBIO - Pressure BioSciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
-0.0500 (-5.15%)
As of 03:11PM EDT. Market open.
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
Previous Close0.9700
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.8800 - 0.9900
52 Week Range0.7100 - 2.2000
Avg. Volume32,973
Market Cap15.431M
Beta (5Y Monthly)0.71
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for PBIO

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • InvestorPlace

    7 Stocks to Sell Right Now… and 1 to Buy

    Once again, I drew the short (no pun intended) end of the stick and must discuss stocks to sell right now. Understandably a sensitive topic and one that arouses myriad emotions, I’m just going to stick with the hard numbers. Whether you agree or not is more of a tertiary issue. Primarily, it’s vital that you at least recognize the obstacles with these investments. To be clear, this list of stocks to sell will not impugn the core narrative of the underlying companies. Frankly, virtually every cap

  • Benzinga

    EXCLUSIVE: Pressure BioSciences Inks Cosmeceuticals Partnership Using Nano Emulsification Platform

    Pressure BioSciences Inc (OTC: PBIO) has teamed up with Dr. Adrienne Denese for a two-year Collaborative Research and Development Agreement. What Happened: Dr. Adrienne Denese is the creator and President of Dr. Denese SkinScience – one of the long-lasting skincare lines in the history of QVC, a part of Qurate Retail Inc (NASDAQ: QRTEA) The companies will prioritize specific skincare projects to pursue. Statements of Work will be developed with approved budgets, timetables, and remuneration form